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Psoriasis is a disease with considerable heterogeneity in clinical presentation. This is the ﬁrst study using two-
dimensional gel electrophoresis to compare global protein expression patterns in lesional and non-lesional skin
from subjects with acute guttate psoriasis associated with streptococcal throat infection and chronic plaque pso-
riasis. Samples from experimentally induced contact eczema and normal skin from healthy controls were also
included. Proteins with statistically significant differences in expression were used in hierarchical cluster analyses
resulting in separation of the different samples into groups. Chronic plaque and guttate psoriasis samples were
distinctly separated, indicating that they represent discrete phenotypes at the protein expression level. Interest-
ingly, there was a trend in which guttate psoriasis lesions clustered closer to eczema than to chronic plaque
psoriasis lesions, indicating that the duration of the inﬂammatory reaction may affect clustering. Several of the
differentially expressed proteins were identiﬁed by mass spectrometry.
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Psoriasis is a common skin disorder that affects 2%–3% of
western population. There is substantial clinical variation
and heterogeneity in disease presentation. The most com-
mon phenotype is chronic plaque psoriasis with well-de-
marcated lesions typically located in the scalp and on the
extensor surfaces. Another disease manifestation is guttate
psoriasis that presents itself as sudden dissemination of
small, red, and scaly papules. Guttate psoriasis is frequently
identified as the first manifestation of the disease in younger
individuals and is reported to develop into chronic plaque
psoriasis in a large proportion of patients (Williams et al,
1976). Flares of guttate psoriasis can also occur in individ-
uals with chronic plaque psoriasis. The etiology and patho-
genesis of psoriasis are still unclear. The inflammatory
process in skin is characterized by an influx of T cells and
neutrophils and a switch of the keratinocyte phenotype to-
wards dedifferentiation and hyperproliferation. Previously
regarded as an epidermal disorder, psoriasis is now prima-
rily considered to be an autoimmune reaction, of which the
precise mechanism(s) remain to be solved (Valdimarsson
et al, 1995; Prinz, 1999).
The genetic contribution to psoriasis is high, and several
psoriasis susceptibility loci (PSORS1–9) on different chro-
mosomes have been identified in genome-wide linkage
studies (HUGO Gene Nomenclature Committee; http://
www.gene.ucl.ac.uk/nomenclature). A major susceptibility
locus is the PSORS1 on chromosome 6p21.3 (Nair et al,
1997; Trembath et al, 1997). This locus contains the human
leukocyte antigen (HLA) genes, and a specific allele of HLA-
C (Cw0602) (Trembath et al, 1997; Bhalerao and Bowcock,
1998) has been shown to be highly associated with psoria-
sis. The genetic background in psoriasis appears to be
complex and whether different psoriasis phenotypes are
associated with distinct genotypes is still unclear. In addi-
tion to genetic susceptibility, environmental factors such as
infection (Gudjonsson et al, 2003), skin trauma (Eyre and
Krueger, 1982), and stress (Seville, 1989; Naldi et al, 2001)
are thought to be responsible for development of the dis-
ease. Streptococcal throat infections are particularly asso-
ciated with the manifestation of guttate psoriasis (Whyte
and Baughman, 1964; Telfer et al, 1992) but are also re-
ported to exacerbate and maintain chronic plaque psoriasis
(Gudjonsson et al, 2003).
Global gene expression in psoriasis has been investigat-
ed in several studies. When comparing lesional and non-
lesional skin from patients with chronic plaque psoriasis and
skin from healthy controls, differentially regulated tran-
scripts were identified (Bowcock et al, 2001; Oestreicher
et al, 2001; Zhou et al, 2003). Based on differences in gene
expression levels, involved skin from psoriasis patients and
healthy skin from controls were differentiated by hierarchical
cluster analysis (Bowcock et al, 2001; Oestreicher et al,
2001). Recently, gene expression profiles were reported
to differ between skin lesions from patients with atopic
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dermatitis and psoriasis (Nomura et al, 2003). At the protein
level, there have been attempts to characterize expression
patterns in psoriasis. Psoriatic keratinocytes have been in-
vestigated by two-dimensional gel electrophoresis (2DE)
(Celis et al, 1990a, b) and in other studies, proteins with
differential expression patterns between lesional psoriatic
and normal skin have been identified (Madsen et al, 1991;
Madsen et al, 1992). There have been no studies, how-
ever, comparing the global protein expression patterns in
patients with well-defined and characterized psoriasis
phenotypes in relation to experimentally induced skin
inflammation.
In this study, the 2DE technique was used to analyze
global protein expression patterns in skin biopsies from in-
dividuals with distinct psoriasis phenotypes, acute contact
eczema and healthy controls. Proteins with statistically sig-
nificant differences in expression patterns were used in hi-
erarchical cluster analysis in order to separate the groups.
Several of the differentially expressed proteins were iden-
tified by mass spectrometry.
Results
Four differentially expressed protein sets were found after
performing the following comparisons through Mann–Whit-
ney analysis and Student’s t test; lesional plaque (n¼ 7)
versus lesional guttate (n¼ 6) protein profiles (60 proteins),
lesional guttate (n¼6) versus lesional eczema (n¼ 4) protein
profiles (64 proteins), lesional guttate (n¼ 6) versus non-
lesional guttate (n¼ 5) protein profiles (34 proteins) and les-
ional plaque psoriasis (n¼ 7) versus lesional eczema (n¼ 4)
protein profiles (164 proteins).
Identiﬁed proteins Twenty-one proteins were identified in
this study (Table S1), of which 12 were found to have more
than 2-fold average up- or downregulation in any group
compared with normal skin (Table I). The selection was
based on the densitometric quantification of the protein
spots. All the identified proteins are marked in the 2D gel
image in Fig 1.
The identified proteins in the 60 protein sets include ca-
lreticulin, cytokeratins 10 and 15, two variants of squamous
cell carcinoma antigen-2 (SCCA-2), also known as leupin,
glutathione S-transferase P (GST-p), maspin, RhoGDP dis-
sociation inhibitor (RhoGDI), and heat shock protein-27
(HSP27). The two SCCA-2 variants differ in pI by approx-
imately 0.2 units, have similar molecular weights and were
upregulated in plaque, guttate, and eczema lesions com-
pared with normal skin. The higher pI variant showed a 38-
and 171-fold upregulation in lesional guttate and plaque,
respectively. The lower pI variant showed a 31- and 139-
fold upregulation, respectively. Calreticulin was downregu-
lated in lesional plaque and guttate psoriasis and in non-
lesional guttate psoriasis skin compared with normal skin,
but slightly upregulated in eczema (Table I). RhoGDI was
upregulated in plaque and guttate psoriasis and also in ec-
zema lesions. Cytokeratins 10 and 15 were downregulated
in plaque and guttate lesions compared with normal, where-
as GST-p, maspin and HSP27 were slightly upregulated in
lesional plaque psoriasis.
Calreticulin and the two variants of SCCA-2 were iden-
tified in the set of 64 proteins, whereas in the 34-protein set
two variants of SCCA-2 and cytokeratin 17 were identified.
Table I. Proteins with more than 2-fold change in plaque
psoriasis compared with normal skin
Protein
Lesional
plaque
Lesional
guttate
Non-lesional
guttate Eczema
SCCA-2, high pI 171 38 1.8 4.3
SCCA-2, low pI 139 31 5.5 3.4
Maspin 1.9 1.3 1.1 2.1
Cytokeratin 10 ND 9 2.8 1.6
Cytokeratin 14 30 4 1.1 1.6
Cytokeratin 15 15 1.3 1.2 1.3
Cytokeratin 17 9 5 1.5 1.4
GST-p 2 1.1 1.2 1.3
HSP27 2 1.1 1.2 1.5
RhoGDI 1 11 5 2.3 12.4
Calreticulin 3 1.1 1.9 1.9
14–3–3 s 3 1.4 1.4 1.1
The fold change between groups is calculated on the basis of average
expression level in each sample type.
SCCA-2, squamous cell carcinoma antigen-2; GST, glutathione S
transferase; HSP, heat shock protein; RhoGDI, RhoGDP dissociation in-
hibitor; ND, not detected; bold, upregulated; –, downregulated.
Figure1
Representative silver-stained two-dimensional (2D) gel image from
lesional guttate psoriasis skin showing the position of the iden-
tified proteins. pI (isoelectric point), kDa (kilo-Dalton), SCCA-2
(squamous cell carcinoma antigen-2), GST (glutathione S transferase),
HSP (heat shock protein), RhoGDI (RhoGDP dissociation inhibitor), Apo
A1 (Apolipoprotein A1).
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Cytokeratin 17 was upregulated in lesional skin from plaque
and guttate psoriasis patients compared with normal skin
from controls (Table I).
Based on these protein data sets, hierarchical cluster
analysis was performed including profiles from all lesional
and non-lesional samples and normal tissue (Table S2). All
four comparisons presented above generated protein data
sets that produced highly similar dendrograms, indicating
that such protein sets were not likely detected by chance
(Fig 2).
Lesional skin from plaque and guttate psoriasis and in-
duced contact eczema separate by proteome analy-
sis All cluster analyses resulted in a clear separation of
lesional plaque psoriasis samples from all other groups. In
addition, profiles from lesional guttate and lesional eczema
clustered in the same branch, although as distinguishable
phenotypes (Fig 2). The fact that samples within each group
clustered together indicates that the protein data sets used
are biologically relevant.
Lesional plaque psoriasis is clearly distinct from all
other groups All comparisons showed that plaque psoria-
sis lesions consistently agglomerated under one separate
branch, whereas the other phenotypes were grouped
on a different cluster (Fig 2). In contrast, non-lesional
samples from the different groups did not show a consist-
ent clustering pattern but were clearly different from plaque
lesions.
Lesional skin from guttate psoriasis clusters closer to
contact eczema than to plaque psoriasis All den-
drograms show that lesional guttate and lesional eczema
samples clustered under the same branch and were con-
sistently positioned separate from plaque psoriasis. Un-
involved and normal samples, however, appeared to
distribute in an inconsistent manner slightly affecting the
grouping around lesional eczema and lesional guttate sam-
ples (Fig 2). This may be due to the small sample size
decreasing the discriminative power of the analysis.
Discussion
This study represents the first global protein analysis of skin
from patients with distinct psoriasis phenotypes. Current
research suggests that there is both clinical and genetic
evidence for heterogeneity in psoriasis, but whether pso-
riasis actually consists of different diseases with distinct
etiologic backgrounds has yet to be resolved. There is con-
siderable overlap in phenotype expression and a single in-
dividual can display different psoriasis manifestations over
time. In this investigation, we chose to study acute guttate
psoriasis and stable chronic plaque psoriasis as clearly
recognizable clinical phenotypes. We hypothesized that the
global protein profiles from such phenotypes would be dis-
tinct, reflecting different disease processes. Considerable
effort was taken to maximize homogeneity among samples,
including only individuals with clear and simple phenotypes
and obtaining all skin biopsies from the same body region.
Moreover, in all guttate patients, we isolated Streptococcus
pyogenes in throat cultures as the likely triggering factor.
Acute guttate flares can occur in patients with chronic
plaque psoriasis and the phenotypes can co-exist in the
same individual. Thus, although these phenotypes may
represent manifestations of the same disease, our results
indicate that they are sufficiently distinct to produce sep-
arable signatures of global protein expression. This is
supported by the finding that the different comparisons
consistently showed similar clustering patters. In addition to
the clear separation between plaque and guttate psoriasis
lesions, we also found a trend in which guttate psoriasis
Figure2
Skin protein profiles from plaque psoriasis, guttate psoriasis and
contact eczema lesions separate by hierarchical cluster analysis.
All dendrograms show that plaque lesions are distinct from the other
phenotypes and that guttate psoriasis and contact eczema are posi-
tioned under the same branch. (a) The cluster analysis was based on 64
proteins with significantly different expression level between lesional
skin from patients with guttate psoriasis and contact eczema. (b) The
cluster analysis was based on 60 proteins with significantly different
expression level between lesional guttate and lesional plaque. (c) Clus-
ter analysis based on 34 proteins differentially expressed between les-
ional and non-lesional guttate psoriasis. (d) Cluster analysis based on
164 proteins with significantly different expression level between les-
ional plaque and lesional eczema. NN (normal), NLG (non-lesional
guttate), LG (guttate), NLE (non-lesional eczema), LE (eczema), NLP
(non-lesional plaque), LP (plaque).
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samples clustered closer to those of contact eczema than
to those of plaque psoriasis. Thus, the duration of the in-
flammatory reaction in skin, acute versus chronic, may af-
fect clustering patterns. Since contact eczema represents a
prototypic T helper 1-driven inflammatory reaction (Grewe
et al, 1998; Cavani et al, 2000), its global protein network
may show similarities to that of acute psoriasis. This ob-
servation underscores the dynamic nature of skin inflam-
mation and is in line with reports from atopic dermatitis,
where the inflammatory and cytokine networks undergo
significant changes over time (Thepen et al, 1996; Grewe
et al, 1998).
Uninvolved skin from any of the phenotypes did not
cluster in a consistent pattern; however, they were all dis-
tinct from lesional plaque samples (Fig 2). Also, there was
no evidence that healthy skin separated from uninvolved
psoriasis or eczema skin, as has been discussed (Uyemura
et al, 1993; de Boer et al, 1994). This may reflect, however,
the small samples sizes in this study that may undermine
the clustering power. Substantially increasing the number of
patients may enhance discrimination.
Some of the proteins identified in this study have been
described previously in psoriasis, for example, cytokeratins
10 and 17 as well as SCCA-2. The protein with the largest
fold upregulation was SCCA-2. It was highly upregulated in
skin from both guttate and plaque psoriasis patients com-
pared with normal skin, which is consistent with recently
published microarray analyses on plaque psoriasis (Bow-
cock et al, 2001; Oestreicher et al, 2001). SCCA-2 belongs
to the serine protease inhibitor superfamily and can be de-
tected in the sera of patients with psoriasis (Hamanaka et al,
1997). It inhibits chymotrypsin-like serine proteinases like
cathepsin G and mast cell chymase (Schick et al, 1997), and
may have a protective role against various proteinases in
pathophysiological events in psoriasis (Takeda et al, 2002).
Previous studies have shown that high serum levels of
SCCA-2 and the intensity of protein expression in lesional
psoriasis skin, correlate with disease activity (Takeda et al,
2002).
HSP27 was upregulated in skin from plaque psoriasis
patients compared with normal skin from controls. HSP27 is
constitutively expressed in epidermis and acts as a chap-
erone in protein folding and as a regulatory protein in actin
polymerization (Jonak et al, 2002; Morris, 2002). Psoriatic
skin contains various HSP, including HSP27 and 70 (Curry
et al, 2003), which have recently come into focus for their
immunomodulatory functions with potential roles in auto-
immune diseases (Asea et al, 2000). HSP27 has been
shown to induce nuclear factor-kB activity in fibroblasts,
which promotes cytokine production leading to T lymph-
ocyte recruitment into the skin (Bell et al, 2003).
RhoGDI was upregulated in both guttate and plaque
psoriasis skin. This protein was described in keratinocytes
by proteome studies (Leffers et al, 1993b) and in psoriasis
by microarray analysis (Bowcock et al, 2001). RhoGDI has
recently been implicated in the signalling cascade control-
ling matrix metalloproteinase-9 in response to keratinocyte
injury and wound healing (Turchi et al, 2003). The Rho family
is involved in cell transformation, motility and adhesion by
regulating the actin cytoskeleton. Regulation of the Rho
family is controlled by a number of activators and inhibitors.
The inhibitors include RhoGDI, which regulates the GDP/
GTP exchange reaction.
14–3–3s was upregulated in lesional plaque psoriasis.
The 14–3–3 family regulates protein kinases and other pro-
teins involved in signal transduction pathways. 14–3–3s has
been found in epithelial cells and mainly in stratified
squamous keratinizing epithelium (Leffers et al, 1993a). Fol-
lowing DNA-damage, 14–3–3s is upregulated by a p53-de-
pendent mechanism and prevents the cell from entering
mitosis (Fu et al, 2000).
Calreticulin was downregulated in lesional plaque pso-
riasis skin. It is a calcium binding protein acting as a
chaperone promoting folding of glycoproteins in the endo-
plasmic reticulum. In addition, it is implicated in calcium
storage and signalling. Downregulation of calreticulin has
been shown to reduce cell attachment through integrin re-
ceptors to extracellular matrix in vitro (Leung-Hagesteijn
et al, 1994).
The expression patterns of cytokeratins in the different
samples were as expected. Keratins 14 and 17 were highly
upregulated, whereas keratins 10 and 15 were markedly
downregulated in plaque psoriasis compared with normal
skin.
We have not found discrepancies with other reports in
terms of the identity of the gene products detected so far in
our study. Concerning the number of identified proteins,
discrepancies with microarray studies may be accounted
for by technical differences. Although microarray analysis is
designed to detect differences in expression patterns within
a set of known transcripts, proteomics deals with the anal-
ysis of 2D profiles within sets of unknown proteins. We have
identified a limited amount of differentially expressed pro-
teins, which are consistent with those reported in the liter-
ature. Qualitative discrepancies between proteome and
microarray data likely arise from post-transcriptional and
post-translational regulation of gene expression (Anderson
and Seilhamer, 1997). A number of RNA transcripts and
proteins previously described as up- or downregulated in
psoriasis skin were not identified in this study, e.g., psoria-
sin (Madsen et al, 1991; Bowcock et al, 2001), SCCA-1
(Rivas et al, 1997) and psoriasis-associated fatty acid bind-
ing protein-5 (Madsen et al, 1992). It is possible, however,
that these proteins were among the differentially expressed
proteins not yet identified in our different data sets. The
analysis by 2DE is limited by the fact that the displayed
proteins represent a fraction of the actual protein content of
the tissue analyzed. In this case, a wide range in protein
expression levels as well as differences in solubility limits
the number of detected proteins. The charge and size
ranges were limited to proteins with a pI between 4 and 7,
and a molecular weight of 10–200 kDa. Detection of pro-
teins of low abundance, such as receptors and proteins in
signal transduction or regulatory pathways, as well as in-
tegral membrane proteins, is limited in this analysis. Despite
these limitations, we were able to separate two distinct
psoriasis phenotypes by hierarchical cluster analysis
and identify proteins with differential expression patterns
between the groups. Additional studies are needed to
integrate the proteins into functional networks and also to
follow dynamics of protein expression through disease
stages and development.
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Materials and Methods
Tissue samples Details regarding patients and controls are pre-
sented in Table S2. Paired biopsies from lesional (n¼ 6) and non-
lesional (n¼ 5) skin were taken from patients with acute untreated
guttate psoriasis. All patients had a concomitant throat infection
and Streptococcus pyogenes was isolated from the throat in all six
patients. Non-lesional skin was obtained at least 10 cm away from
the psoriasis lesion. Lesional (n¼ 7) and non-lesional samples
(n¼ 3) from patients with stable chronic plaque psoriasis, without
topical or systemic treatment for at least 2 mo, were also included.
Paired samples were obtained from one patient. The plaque pso-
riasis skin lesions were clinically comparable in thickness with the
guttate psoriasis lesions. Control samples were taken from four
healthy individuals with no family history of psoriasis as reference
for the normal skin protein pattern. In four individuals with known
contact allergy to nickel but otherwise healthy, paired biopsy
specimens were taken from positive patch test reactions to 5%
nickel sulfate, and from non-lesional skin (n¼ 3). The patch testing
was performed in a standardized manner using polypropylene-
coated Finn chambers (Epitest, Helsinki, Finland) mounted on
Scanpor (Norgeplaster, Oslo, Norway) for 72 h. All skin samples
from patients and controls were obtained from the lower back us-
ing a 6 mm biopsy punch to a depth of 7 mm and were snap-frozen
and stored at 701C. All biopsies were taken with written informed
consent and with approval of the Karolinska Institute Committee of
Ethics. The study was conducted according to the Declaration of
Helsinki Principles.
Sample preparation The skin biopsies were kept frozen in liquid
nitrogen and mechanically homogenized using a mortar and pestle.
Samples were then solubilized in a volume of (six times tissue wet
weight (WW)) mL lysis buffer containing 9 M urea (Sigma-Aldrich,
Stockholm, Sweden), 2 M thiourea (Sigma-Aldrich), 1 mM EDTA
(Merck Biosciences, Nottingham, UK), 65 mM DTT (BioRad, Stock-
holm, Sweden), 0.2 mM PMSF (Amersham Biosciences, Uppsala,
Sweden), 0.8 mM benzamidine (Sigma-Aldrich), 25 mM CHAPS
(Sigma-Aldrich, 5% Resolyte (pH 4–8) (BDH Laboratory Suppliers,
Poole, UK), and 5% Nonidet P40 (Amersham Biosciences). A vol-
ume of (0.089 times WW) mL 10% SDS (Shelton Scientific, Shelton,
Connecticut), including 33.3% mercaptoethanol (Sigma-Aldrich)
and a volume of (0.329 times WW) mL of a solution of DNase I (3.72
U per mL) (Worthington, Lakewood, New Jersey) and RNase A
(0.036 U per mL) (Quiagen, Valencia, California), was also added.
The mixture was incubated on a shaker at room temperature for 3 h
and then centrifuged at 12,000  g to remove any insoluble ma-
terial. Protein concentration was determined using the Bradford
method (BioRad Protein Assay, BioRad) (Bradford, 1976).
Electrophoresis For first dimension, 100 mg total protein were
dissolved in rehydration buffer, containing 0.5% (vol/vol) IPG-buffer
pH 4–7 (Amersham Biosciences), 7 M urea, 2 M thiourea (Sigma-
Aldrich), 65 mM CHAPS, 0.5% Triton X-100 (Sigma-Aldrich), and
18 mM DTT (BioRad) to a final volume of 350 mL and loaded onto
an 18 cm IPG-strip pH 4–7 with linear pH gradient (Immobiline
DryStrip, Amersham Biosciences). Isoelectric focusing was per-
formed using Ettan IPGphor Isoelectric Focusing System (Amer-
sham Biosciences). Before separation of the second dimension,
the gel strips were equilibrated for 15 min with 50 mM Tris-HCl
(Shelton Scientific, Shelton, Connecticut), pH 6.8, containing 6 M
urea, 30% glycerol, 2% SDS, and 65 mM DTT, to reduce disulfide
bonds to allow the proteins to unfold, and 15 min with 50 mM Tris-
HCl, pH 8.8, containing 6 M urea, 30% glycerol, 2% SDS, and 135
mM iodoacetamide (Sigma-Aldrich) to alkylate thiol groups on
proteins. The second dimension was carried out in an 18  20 cm
SDS polyacrylamide gel with acrylamide:N,N0-ethylenebisacryl-
amide (37.5:1) (BioRad) with 10%–13% gradient in 192 mM glycine
running buffer using Hoefer Dalt 2-D Electrophoresis System
gel tank and the Hoefer EPS2A200 power supply (Amersham
Biosciences).
Gel staining and image analysis Protein spots were visualized
by staining with silver nitrate (Rabilloud et al, 1994). A represent-
ative gel of guttate psoriasis is shown in Fig 1. Silver stained gels
were scanned at 100 mm resolution using a laser densitometer
(BioRad), and data were analyzed using the PDQuest software
(version 7.1.1, BioRad). Automatic spot detection was performed
by PDQuest, which assigned identities according to the Standard
Spot number assignment algorithm (SSP). Spot matching was
also automatic in the initial phase but complemented with visual
landmark assignment (20 spots per gel) and inspection of spot
matching in the quality control phase. Final inclusion of spots
in the analysis was done after specific quality control criteria
were fulfilled. These included; having density measurements above
a certain detection threshold, discarding artifacts, checking for
local distortions on gels, checking for vector offsets, etc. The
inclusion threshold was defined according to spot attributes such
as: Gaussian fit, horizontal and vertical gel streaking, degree of
spot overlap, and scanner linearity.
Data analysis Different hypotheses concerning the characteristics
of the phenotypes were tested by first selecting different subsets of
proteins, using PDQuest. Each subset of proteins was formed by
selecting proteins with significantly different expression in two
specified groups. A protein was considered to have significantly
different expression if both Mann–Whitney’s test and Student’s t
test yielded a p-value less than or equal to 0.02. The subsets were
exported from PDQuest to Excel, where each exported subset
consisted of the quantitative values of all spots corresponding to
the significant proteins. Quantitative values of absent spots in the
exported datasets, which are normally represented as 1, were
changed to 1.
The exported datasets were analyzed by hierarchical cluster
analysis using the mva and vegan libraries in R (http://cran.r-
project.org/). Hierarchical cluster analysis groups similar samples
together in an agglomerative way based on a calculated distance
matrix (Dysvik and Jonassen, 2001). Here, the distance matrix was
calculated using the Bray–Curtis distance function and the clusters
were formed using the complete linkage procedure.
Gel staining for protein identiﬁcation Protein spots with statis-
tically significant variability in the expression pattern between the
samples were selected for identification by mass spectrometry.
Gels were stained with Coomassie blue or SYPRO Ruby. For Coo-
massie staining, IPG-strips were loaded with 750 mg total protein
and the resulting two-dimensional gels were stained with colloidal
Coomassie blue (Sigma-Aldrich). Gels were fixed in 50% ethanol
and 2% phosphoric acid (Merck Biosciences, Nottingham, UK)
over night and washed 3 times 30 min in deionized water. The gels
were then soaked in 34% methanol (Merck Biosciences, Notting-
ham, UK), 3% phosphoric acid and 1.3 M ammonium sulfate (Si-
gma-Aldrich) for 1 h before adding Coomassie powder (680 mg per
liter). The gels were stained for 4–8 d and were then destained and
washed in deionized water. For SYPRO Ruby staining, IPG-strips
were loaded with 500 mg total protein and the SYPRO Ruby protein
gel stain (BioRad) was used according to the manufacturer’s
recommendations.
Spot picking and in-gel digestion Protein spots from 2D gels
stained with Coomassie blue were picked manually and transferred
to 500 mL Eppendorf tubes. The gel pieces were washed overnight
in 30% methanol to remove the Coomassie stain. The pieces were
then washed 5 min with 50% 50 mM ammonium bicarbonate
(Ambic) in 50% acetonitrile (ACN) and briefly washed in ACN be-
fore adding trypsin (0.5 mg). Digestion was performed over night at
371C on a shaker and the peptides were extracted from the gel
piece with 50% ACN with 0.1% trifluoroacetic acid (TFA). Samples
were completely dried in a vacuum centrifuge and analyzed by
matrix-assisted laser desorption ionisation-time of flight (MALDI-
TOF) or liquid chromatography-quadropole time of flight tandem-
MS (LC-MS/MS). For MALDI-TOF, samples were dissolved in 2 mL
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60% ACN with 0.1% TFA and mixed with 2 mL a-cyano-4-hydro-
xycinnamic acid dissolved in 50% ACN/50% ethanol (10 mg per
mL) and loaded onto a MALDI plate for MALDI-TOF mass spect-
rometry (Waters, Milford, Massachusetts). Mass spectra were
analyzed and matched to SWISS-PROT database entries using
Mascot available at http://www.matrixscience.com. Matches were
computed using a probability-based Mowse score defined as
10  Log p, where p is the probability that the observed match is
a random event. Protein scores greater than 72 were considered
significant (po0.05). For LC-MS/MS, samples were analyzed by
means of a Waters Micromass modular capillary LC system con-
nected directly to the source of a Q-TOF mass spectrometer (Wa-
ters), as described (Allardyce et al, 2002). The data were processed
by ProteinLynx Global Server v2.0 (Waters) and protein identifica-
tion was achieved by matching both peptide mass and fragment
ion data to proteins contained within the SWISSPROT protein
database.
Protein spots from 2D gels stained with SYPRO Ruby were
picked automatically using the ProteomeWorks Spot Cutter Sys-
tem with PDQuest Basic Excision Software (BioRad) and placed in
96-well microtiter plates. All spots were then digested using the
MassPREP robotic protein handling system (Waters). The protocol
for the robotic system is based on in-gel digestion methods as
described (Roblick et al, 2004). Peptide solutions were concen-
trated and desalted using a Gyrolab MALDI CD in a Gyrolab Work-
station (Gyros AB, Uppsala, Sweden) (Gustafsson et al, 2004) and
crystallized onto MALDI targets for MALDI-TOF mass specrometry.
Mass spectra were analyzed and matched to SWISS-PROT data-
base entries using ProteinProspector available at http://prospector.
ucsf.edu/.
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